NCT01451463View on ClinicalTrials.gov

Impact of Xenazine(Tetrabenazine)on Gait and Functional Activity in Individuals With Huntington's Disease

CompletedOBSERVATIONAL
Enrollment

11

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Huntington's Disease
Trial Locations (1)

43210

The Ohio State University Medical Center, Columbus

Sponsors

Collaborators (1)

Lundbeck LLC
All Listed Sponsors
collaborator

Lundbeck LLC

INDUSTRY

lead

Ohio State University

OTHER